The post Scilex Finalizes $150M Bitcoin Investment in Datavault AI appeared on BitcoinEthereumNews.com. Key Points: Scilex completes a substantial Bitcoin investment in Datavault AI. Marks a shift for Scilex towards digital asset integration. Signals confidence in healthcare-oriented data solutions. Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets. This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors. Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval. DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm. “We are thrilled to secure this strategic investment from Scilex, which demonstrates strong cross-sector confidence in our data solutions for the healthcare and biotechnology verticals.” — Nathaniel Bradley, CEO, Datavault AI Bitcoin’s Role in Cross-Sector Biotech Investments Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments. According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened… The post Scilex Finalizes $150M Bitcoin Investment in Datavault AI appeared on BitcoinEthereumNews.com. Key Points: Scilex completes a substantial Bitcoin investment in Datavault AI. Marks a shift for Scilex towards digital asset integration. Signals confidence in healthcare-oriented data solutions. Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets. This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors. Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval. DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm. “We are thrilled to secure this strategic investment from Scilex, which demonstrates strong cross-sector confidence in our data solutions for the healthcare and biotechnology verticals.” — Nathaniel Bradley, CEO, Datavault AI Bitcoin’s Role in Cross-Sector Biotech Investments Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments. According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened…

Scilex Finalizes $150M Bitcoin Investment in Datavault AI

Key Points:
  • Scilex completes a substantial Bitcoin investment in Datavault AI.
  • Marks a shift for Scilex towards digital asset integration.
  • Signals confidence in healthcare-oriented data solutions.

Scilex Holding Company, Nasdaq-listed, finalizes a $150 million Bitcoin investment in Datavault AI, marking a strategic shift from traditional biotech investments into digital assets.

This transaction highlights a rare move by biotech firms towards digital currencies, potentially influencing market dynamics within the biotechnology and AI sectors.

Scilex’s Bold Move: First Biotech Bitcoin Investment on Nasdaq

Scilex Holding Company has completed the first tranche of a $150 million investment into Datavault AI Inc. using Bitcoin. This initial tranche involves 15 million shares at $0.5378 per share, with provisions to reach 278.9 million shares upon shareholder approval.

DataVault AI Secures $150 Million Investment for Growth marks a notable shift from its traditional non-opioid therapy focus, demonstrating a strategic interest in digital assets. The use of Bitcoin in this transaction is a first for a publicly listed biotech firm.

Bitcoin’s Role in Cross-Sector Biotech Investments

Did you know? Scilex’s Bitcoin investment is unique as it marks the first notable use of a digital currency by a biotech firm on Nasdaq, highlighting an evolving landscape in cross-sector investments.

According to CoinMarketCap, Bitcoin currently stands at $110,231.55 with a market cap of 2,196,630,883,322 and a 24-hour trading volume of 26,457,395,255. Over the past 90 days, Bitcoin has seen a 2.78% price increase.

Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:53 UTC on September 28, 2025. Source: CoinMarketCap

Coincu research suggests this strategic move may encourage more biotech firms to explore digital asset transactions and could lead to heightened industry collaborations. Regulatory responses remain crucial, considering Bitcoin’s evolving role in diverse investments.

Source: https://coincu.com/news/scilex-bitcoin-investment-completion/

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Channel Factories We’ve Been Waiting For

The Channel Factories We’ve Been Waiting For

The post The Channel Factories We’ve Been Waiting For appeared on BitcoinEthereumNews.com. Visions of future technology are often prescient about the broad strokes while flubbing the details. The tablets in “2001: A Space Odyssey” do indeed look like iPads, but you never see the astronauts paying for subscriptions or wasting hours on Candy Crush.  Channel factories are one vision that arose early in the history of the Lightning Network to address some challenges that Lightning has faced from the beginning. Despite having grown to become Bitcoin’s most successful layer-2 scaling solution, with instant and low-fee payments, Lightning’s scale is limited by its reliance on payment channels. Although Lightning shifts most transactions off-chain, each payment channel still requires an on-chain transaction to open and (usually) another to close. As adoption grows, pressure on the blockchain grows with it. The need for a more scalable approach to managing channels is clear. Channel factories were supposed to meet this need, but where are they? In 2025, subnetworks are emerging that revive the impetus of channel factories with some new details that vastly increase their potential. They are natively interoperable with Lightning and achieve greater scale by allowing a group of participants to open a shared multisig UTXO and create multiple bilateral channels, which reduces the number of on-chain transactions and improves capital efficiency. Achieving greater scale by reducing complexity, Ark and Spark perform the same function as traditional channel factories with new designs and additional capabilities based on shared UTXOs.  Channel Factories 101 Channel factories have been around since the inception of Lightning. A factory is a multiparty contract where multiple users (not just two, as in a Dryja-Poon channel) cooperatively lock funds in a single multisig UTXO. They can open, close and update channels off-chain without updating the blockchain for each operation. Only when participants leave or the factory dissolves is an on-chain transaction…
Share
BitcoinEthereumNews2025/09/18 00:09
‘KPop Demon Hunters’ Gets ‘Golden’ Ticket With 2 Nominations

‘KPop Demon Hunters’ Gets ‘Golden’ Ticket With 2 Nominations

The post ‘KPop Demon Hunters’ Gets ‘Golden’ Ticket With 2 Nominations appeared on BitcoinEthereumNews.com. Mira (voice of May Hong), Rumi (Arden Cho) and Zoey (
Share
BitcoinEthereumNews2026/01/22 23:28
Tron Founder Justin Sun Invests $8M in River’s Stablecoin Abstraction Technology

Tron Founder Justin Sun Invests $8M in River’s Stablecoin Abstraction Technology

Justin Sun commits $8 million to River for stablecoin abstraction deployment across Tron ecosystem, including SUN pools and JustLend integration, as RIVER token
Share
Coinstats2026/01/22 22:59